Finance

Beta
Lists
187660:KOSDAQ
Penetrium Bioscience Inc
₩6,340.00
+1.12%
(+70.00) 1D
Jun 11, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 187660...
Open
₩6,200
High
₩6,400
Low
₩6,000
Mkt. cap
351.66B
Avg. vol.
1.67M
Volume
371.91K
52-wk high
₩21,500
52-wk low
₩1,118
EPS
-₩253
Shares outstanding
55.47M
No. of employees
110
Open
₩6,200
High
₩6,400
Low
₩6,000
Mkt. cap
351.66B
Avg. vol.
1.67M
Volume
371.91K
52-wk high
₩21,500
52-wk low
₩1,118
EPS
-₩253
Shares outstanding
55.47M
No. of employees
110
News stories
From sources across the web
About Penetrium Bioscience Inc
CEOJong-Eon Lim
Employees110
Founded2003
Headquarters-
SectorHealth care
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Revenue
2.93B
2.63B
2.04B
-
Cost of goods sold
3.09B
2.39B
2.29B
-
Cost of revenue
3.09B
2.39B
2.29B
-
Research and development expenses
260.87M
9.33B
1.03B
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.09B
1.19B
987.24M
-
Operating expense
1.61B
10.80B
2.33B
-
Total operating expenses
4.70B
13.19B
4.62B
-
Operating income
-1.77B
-10.57B
-2.58B
-
Other non operating income
85.37K
-2.16B
-79.27M
-
EBT including unusual items
-1.67B
-12.67B
-3.79B
-
EBT excluding unusual items
-1.82B
-12.56B
-3.03B
-
Income tax expense
-180.75M
54.99M
-
-
Effective tax rate
10.85%
-0.43%
-
-
Other operating expenses
35.18M
30.78M
41.01M
-
Net income
-1.40B
-12.48B
-3.57B
-
Net profit margin
-47.62%
-475.14%
-174.38%
-
Earnings per share
-
-
-
-
Interest and investment income
186.32M
213.71M
70.18M
-
Interest expense
-214.13M
-73.78M
-448.74M
-
Net interest expenses
-27.81M
139.93M
-378.56M
-
Depreciation and amortization charges
183.19M
208.24M
234.15M
-
EBITDA
-1.35B
-10.15B
-2.18B
-
Gain or loss from assets sale
9.61M
-
742.90M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more